EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSIPUG00000013718
Gene Symbol: DHCR24
3 Cross references
208 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 13

Ensembl ID : ENSIPUG00000011120
Gene Symbol: LOC108270933
3 Cross references
208 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase A

Ensembl ID : ENSIPUG00000018368
Gene Symbol: HMGCRA
3 Cross references
152 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase B

Ensembl ID : ENSIPUG00000014685
Gene Symbol: HMGCRB
4 Cross references
205 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1a

Ensembl ID : ENSIPUG00000019368
Gene Symbol: PDPK1A
3 Cross references
170 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1b

Ensembl ID : ENSIPUG00000000337
Gene Symbol: PDPK1B
4 Cross references
221 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSIPUG00000008226
Gene Symbol: LOC108264894
4 Cross references
204 Possible Orthologues:

5'-Nucleotidase, Ecto (Cd73)

Ensembl ID : ENSIPUG00000008104
Gene Symbol: NT5E
3 Cross references
215 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 1a B

Ensembl ID : ENSIPUG00000004938
Gene Symbol: HTR1AB
1 Cross references
137 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2a, Genome Duplicate B

Ensembl ID : ENSIPUG00000019516
Gene Symbol: HTR2AB
3 Cross references
207 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2b, G Protein-Coupled

Ensembl ID : ENSIPUG00000024583
Gene Symbol: HTR2B
3 Cross references
201 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2c, G Protein-Coupled-Like 1

Ensembl ID : ENSIPUG00000022838
Gene Symbol: HTR2CL1
4 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).